Cite
HARVARD Citation
Ujvari, D. et al. (2022). IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors. Oncoimmunology. p. . [Online].